filmarray respiratory panel 2.1 (BioFire Defense)
90
Structured Review
BioFire Defense
filmarray respiratory panel 2.1
Filmarray Respiratory Panel 2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/filmarray+respiratory+panel/filmarray+respiratory+panel/pm40573450-1-34-33
Average 90 stars, based on 1 article reviews
Filmarray Respiratory Panel 2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/filmarray+respiratory+panel/filmarray+respiratory+panel/pm40573450-1-34-33
Average 90 stars, based on 1 article reviews
filmarray respiratory panel 2.1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Diagnostic Assay:Article Title: Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Article Snippet: James W. Antoon, Justin Z. Amarin, Olla Hamdan, Tess Stopczynski, Laura S. Stewart, Marian G. Michaels, John V. Williams, Eileen J. Klein, Janet A. Englund, Geoffrey A. Weinberg, Peter G. Szilagyi, Jennifer E. Schuster, Rangaraj Selvarangan, Christopher J. Harrison, Julie A.. Boom, Leila C. Sahni, Flor M. Muñoz, Mary Allen Staat, Elizabeth P. Schlaudecker, James D. Chappell, Benjamin R. Clopper, Heidi L. Moline, Angela P. Campbell, Andrew J. Spieker, Samantha M. Olson, and Natasha B. Halasa Vanderbilt University Medical Center, Nashville, Tennessee, USA; Epidemiology Doctoral Program, Vanderbilt University, Nashville, Tennessee, USA; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; Seattle Children’s Research Institute, Seattle, Washington, USA; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA; UCLA Mattel Children’s Hospital and Department of Pediatrics, University of California at Los Angeles, Los Angeles, California, USA; Children’s Mercy Hospital and University of Missouri–Kansas City, Kansas City, Missouri, USA; Texas Children’s Hospital and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; and Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Reverse Transcription Polymerase Chain Reaction:Article Title: Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Article Snippet: James W. Antoon, Justin Z. Amarin, Olla Hamdan, Tess Stopczynski, Laura S. Stewart, Marian G. Michaels, John V. Williams, Eileen J. Klein, Janet A. Englund, Geoffrey A. Weinberg, Peter G. Szilagyi, Jennifer E. Schuster, Rangaraj Selvarangan, Christopher J. Harrison, Julie A.. Boom, Leila C. Sahni, Flor M. Muñoz, Mary Allen Staat, Elizabeth P. Schlaudecker, James D. Chappell, Benjamin R. Clopper, Heidi L. Moline, Angela P. Campbell, Andrew J. Spieker, Samantha M. Olson, and Natasha B. Halasa Vanderbilt University Medical Center, Nashville, Tennessee, USA; Epidemiology Doctoral Program, Vanderbilt University, Nashville, Tennessee, USA; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; Seattle Children’s Research Institute, Seattle, Washington, USA; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA; UCLA Mattel Children’s Hospital and Department of Pediatrics, University of California at Los Angeles, Los Angeles, California, USA; Children’s Mercy Hospital and University of Missouri–Kansas City, Kansas City, Missouri, USA; Texas Children’s Hospital and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; and Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Article Title: Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020 Article Snippet: .. Respiratory specimens were tested for influenza virus using the NxTAG Respiratory Pathogen Panel (Luminex; in California, Missouri, and Ohio), Polymerase Chain Reaction:Article Title: Pneumococcal colonization dynamics among young children with and without respiratory symptoms during the first year of the SARS-CoV-2 pandemic. Article Snippet: .. The symptomatic group consisted of children with respiratory symptoms that sought care at CMKC and required SARS-CoV-2 PCR and/or other viral PCR testing ( other:Article Title: Impact of Acute Respiratory Infections on Medical Absenteeism Among Military Personnel: Retrospective Cohort Study. Article Snippet: The study used data from comprehensive surveillance with the Modification:Article Title: Real-world use and treatment outcomes of ceftazidime-avibactam in gram-negative bacterial infection in Taiwan: A multicenter retrospective study. Article Snippet: Objectives: Ceftazidime-avibactam (CAZ-AVI) has been launched in Asian countries for five years, but local real-world data about patient characteristics, efficacy, and safety of CAZ-AVI is limited.. We conducted a multicenter, retrospective study to investigate the clinical characteristics, microbiology, and outcomes of patients treated with CAZ-AVI for Gram-negative bacterial infection in Taiwan.. Methods: This investigation was conducted as a multicenter retrospective cohort study involving five medical centers in Taiwan. Diffusion-based Assay:Article Title: Real-world use and treatment outcomes of ceftazidime-avibactam in gram-negative bacterial infection in Taiwan: A multicenter retrospective study. Article Snippet: Objectives: Ceftazidime-avibactam (CAZ-AVI) has been launched in Asian countries for five years, but local real-world data about patient characteristics, efficacy, and safety of CAZ-AVI is limited.. We conducted a multicenter, retrospective study to investigate the clinical characteristics, microbiology, and outcomes of patients treated with CAZ-AVI for Gram-negative bacterial infection in Taiwan.. Methods: This investigation was conducted as a multicenter retrospective cohort study involving five medical centers in Taiwan. CRAfT Assay:Article Title: Palm-sized CRISPR sensing platform for on-site Mycoplasma pneumoniae detection. Article Snippet: Pneumonia remains a prevalent childhood illness and is the foremost cause of mortality due to infectious diseases among children under the age of five.. Mycoplasma pneumoniae (M. pneumoniae) causes the most frequent type of atypical pneumonia in this age group, has raised global health concern.. Therefore, there is a pressing need for a rapid, low cost, and user-friendly method for the early diagnosis of M. pneumoniae pneumonia. Virus:Article Title: Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020 Article Snippet: .. Respiratory specimens were tested for influenza virus using the NxTAG Respiratory Pathogen Panel (Luminex; in California, Missouri, and Ohio), |